首页> 外文期刊>Disaster and military medicine. >Fluid resuscitation in haemorrhagic shock in combat casualties
【24h】

Fluid resuscitation in haemorrhagic shock in combat casualties

机译:战斗伤员出血性休克中的液体复苏

获取原文
       

摘要

This brief update reviews the recent literature available on fluid resuscitation from hemorrhagic shock and considers the applicability of this evidence for use in resuscitation of combat casualties in the combat casualty care (CCC) environment. A number of changes need to be incorporated in the CCC guidelines: (1) dried plasma (DP) is added as an option when other blood components or whole blood are not available; (2) the wording is clarified to emphasize that Hetastarch is a less desirable option than whole blood, blood components, or DP and should be used only when these preferred options are not available; (3) the use of blood products in certain tactical field care settings where this option might be feasible (FSC, GH) is discussed; (4) 1:1:1 damage control resuscitation (DCR) with plasma: packed red blood cells (PRBC): platelets is preferred to 1:1 DCR with plasma: PRBC when platelets are available; and (5) the 30-min wait between increments of resuscitation fluid administered to achieve clinical improvement or target blood pressure has been eliminated. Also included is an order of precedence for resuscitation fluid options. There should be an emphasis on hypotensive resuscitation in order to minimize (1) interference with the body’s hemostatic response and (2) the risk of complications of over resuscitation. Hetastarch is retained as the preferred option over crystalloids when blood products are not available because of its smaller volume and the potential for long evacuations in the military setting.
机译:本简要更新回顾了有关失血性休克进行液体复苏的最新文献,并考虑了该证据在战斗伤亡护理(CCC)环境中用于战斗伤亡复苏的适用性。 CCC指南中需要进行许多更改:(1)当没有其他血液成分或全血时,可以添加干燥血浆(DP)作为选择; (2)澄清措词以强调,与全血,血液成分或DP相比,Hetastarch是较不理想的选择,并且仅当这些首选选项不可用时才应使用; (3)讨论了在某些战术性现场护理环境中使用这种血液制品的可能性(FSC,GH); (4)有血浆的1:1:1损伤控制复苏(DCR):充盈的红细胞(PRBC):与有血浆的PRDC相比,首选血小板:PRBC(如果有血小板可用);与血浆的PRDC 1:1: (5)消除了在增加复苏液之间等待30分钟以达到临床改善或目标血压的等待时间。还包括复苏液选择的优先顺序。为了减少(1)对人体止血反应的干扰,以及(2)过度复苏引起并发症的风险,应该着重进行降压复苏。当无法获得血液制品时,Hetastarch仍然是首选替代晶体的产品,因为其体积较小且在军事环境中可能会长期撤离。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号